BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 10, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Prostate cancer vaccine: Phase I/II data

Medical Marketing International Group plc (LSE:MMG), Cambridge, U.K.
Product: Prostate cancer vaccine
Business: Cancer
Molecular target: Prostate-specific membrane antigen ( PSMA)
Description: DNA vaccine against prostate specific...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >